Full View

Outcomes in patients with hypertrophic cardiomyopathy and left ventricular systolic dysfunction

EJ Rowin, BJ Maron, RT Carrick, PP Patel… - Journal of the American …, 2020 - jacc.org
Background End-stage (ES) hypertrophic cardiomyopathy (HCM) has been considered a
particularly grim and unfavorable disease complication, associated with substantial …
被引用次数：119 相关文章
[HTML] sciencedirect.com

[HTML][HTML] Outcomes in Patients With Hypertrophic Cardiomyopathy and Left Ventricular Systolic Dysfunction

EJ Rowin, BJ Maron, RT Carrick, PP Patel… - Journal of the American …, 2020 - Elsevier
Background End-stage (ES) hypertrophic cardiomyopathy (HCM) has been considered a
particularly grim and unfavorable disease complication, associated with substantial …

Outcomes in Patients With Hypertrophic Cardiomyopathy and Left Ventricular Systolic Dysfunction

EJ Rowin, BJ Maron, RT Carrick… - Journal of the …, 2020 - pubmed.ncbi.nlm.nih.gov
Background End-stage (ES) hypertrophic cardiomyopathy (HCM) has been considered a
particularly grim and unfavorable disease complication, associated with substantial …

Outcomes in Patients With Hypertrophic Cardiomyopathy and Left Ventricular Systolic Dysfunction.

EJ Rowin, BJ Maron, RT Carrick, PP Patel… - Journal of the …, 2020 - europepmc.org
Background End-stage (ES) hypertrophic cardiomyopathy (HCM) has been considered a
particularly grim and unfavorable disease complication, associated with substantial …

[引用][C] Outcomes in Patients With Hypertrophic Cardiomyopathy and Left Ventricular Systolic Dysfunction

EJ Rowin, BJ Maron, RT Carrick, PP Patel… - Journal of the American …, 2020 - cir.nii.ac.jp